Developed skills and lines of research

Carlo Laudanna earned his degree in Medicine and Surgery in 1988 from the University of Verona. He later obtained a Master’s in Molecular Biology in 1992 and a PhD in Pathology and Molecular and Cellular Biology in 1996 from the University of Verona, including a tenure at Stanford University, CA, USA.

Since 2001, he has been the director of the Cell Trafficking and Signal Transduction Laboratory in the Department of Medicine at the University of Verona and has been a Full Professor in the same department since 2010.

Since joining the Institute of General Pathology as an internal student in 1984 and following his graduation, Laudanna has focused on pro-inflammatory leukocyte activity, particularly leukocyte adhesion and chemotactic functions and the second messenger systems regulating them. For FFC Ricerca, he works on demonstrating that measuring LFA-1 activation in monocytes can be used to monitor the outcomes of patient treatments with modulator drugs. These studies could enable a personalized approach to cystic fibrosis treatment. Professor Laudanna is the co-founder of two start-ups and holds four international patents.

Projects funded by FFC Ricerca as Principal Investigator or as Research Manager

FFC#7/2021
Monocyte integrin activation as a cystic fibrosis drug evaluation test: validation phase

FFC#13/2019
Monocyte integrin activation as a cystic fibrosis drug evaluation test

Projects financed by FFC Ricerca as a partner

FFC#23/2015
Targeting PI3Kγ scaffold function to activate airway CFTR, limit lung inflammation and promote bronchorelaxation in cystic fibrosis

FFC#25/2014
Targeting PI3Kγ scaffold function to activate airway CFTR, limit lung inflammation and promote bronchorelaxation in cystic fibrosis